Jefferson Luis de Barros

Jefferson Luis de Barros

Auto-generated profile, based on publicly available information

Jefferson Luis de Barros

Universidade Estadual de São Paulo (UNESP), Faculdade de Medicina de Botucatu, Botucatu, SP, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2015 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
RMRenato Oliveira Martins
Renato Oliveira Martins
NCNuria Castello-Branco
Nuria Castello-Branco
JBJefferson Luis de Barros
Jefferson Luis de Barros
SWSilke Anna Theresa Weber
Silke Anna Theresa Weber
Objective: To identify risk factors for respiratory complications after adenotonsillectomy in children ≤ 12 years of age with obstructive sleep apnea who were referred to the pediatric ICU (PICU). Methods: A cross-sectional historical cohort study analyzing 53 children after adenotonsillectomy who met predetermined criteria for PICU referral in a tertiary level teaching hospital. The Student's t-test, Mann-Whitney test, and chi-square test were used to identify risk factors. Results: Of the 805 children undergoing adenotonsillectomy between January of 2006 and December of 2012 in the teaching hospital, 53 were referred to the PICU. Twenty-one children (2.6% of all those undergoing adenotonsillectomy and 39.6% of those who were referred to the PICU) had respiratory complications. Of those 21, 12 were male. The mean age was 5.3 ± 2.6 years. A high apnea-hypopnea index (AHI; p = 0.0269), a high oxygen desaturation index (ODI; p = 0.0082), a low SpO2 nadir (p = 0.0055), prolonged orotracheal intubation (p = 0.0011), and rhinitis (p = 0.0426) were found to be independent predictors of respiratory complications. Some of the complications observed were minor (SpO2 90-80%), whereas others were major (SpO2 ≤ 80%, laryngospasm, bronchospasm, acute pulmonary edema, pneumonia, and apnea). Conclusions: Among children up to 12 years of age with OSA, those who have a high AHI, a high ODI, a low SpO2 nadir, or rhinitis are more likely to develop respiratory complications after adenotonsillectomy than are those without such characteristics.

1 May 2018 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
FPFlávio Danilo Mungo Pissulin
Flávio Danilo Mungo Pissulin
FPFrancis Pacagnelli
Francis Pacagnelli
MAMaiara Almeida Aldá
Maiara Almeida Aldá
RBRicardo Beneti
Ricardo Beneti
JBJefferson Luis de Barros
Jefferson Luis de Barros
SWSilke Anna Theresa Weber
Silke Anna Theresa Weber
Objective: To investigate whether the presence of obstructive sleep apnea syndrome (OSAS) alters the perception of respiratory symptoms and quality of life in COPD patients, by using specific questionnaires, as well as to determine whether scales for assessing daytime sleepiness and for screening for OSAS can be used in the triad of OSAS, COPD, and obesity. Methods: We included 66 patients diagnosed with mild-to-moderate or severe COPD and presenting with a body mass index > 27 kg/m2. After polysomnography, patients completed the Epworth sleepiness scale (ESS), the Berlin questionnaire (BQ), the modified Medical Research Council (mMRC) scale, the Baseline Dyspnea Index (BDI), and the Saint George’s Respiratory Questionnaire (SGRQ). Results: Patients were first divided into two groups: COPD + OSAS (n = 46); and COPD-only (n = 20). The COPD + OSAS group was subdivided into a COPD + mild-to-moderate OSAS group (n = 32) and a COPD + severe OSAS group (n = 14), all of which were compared with the COPD-only group. There was a significant difference in mean FEV1 (L) between the COPD + OSAS groups and the COPD-only group (p = 0.073). The presence of the triad did not lead to significantly higher ESS scores, and scores > 10 had a specificity of 0.58. The BQ did not identify high risk for OSAS in the presence of the triad (specificity of 0.31). There were no significant differences in domain or total scores of the SGRQ between the COPD + OSAS groups and the COPD-only group. Conclusions: The confounding factors present in the triad of OSAS, COPD, and obesity prevented the perception of increased daytime sleepiness and high risk for OSAS. We observed no worsening of dyspnea perception or quality of life.

1 November 2022 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
JPJefferson Luis de Barros Phys
Jefferson Luis de Barros Phys
WRWillian Caetano Rodrigues
Willian Caetano Rodrigues
AMAntônio Carlos Marão
Antônio Carlos Marão
LALetícia Cláudia de Oliveira Antunes
Letícia Cláudia de Oliveira Antunes
STSérgio Henrique Kiemle Trindade
Sérgio Henrique Kiemle Trindade
SWSilke Anna Theresa Weber
Silke Anna Theresa Weber
Obesity is the most frequent reversible agravating factor of obstructive sleep apnea syndrome, with physical activity very important for its control. Continuous positive air pressure during sleep is the "gold standard" treatment for obstructive sleep apnea syndrome. we aimed to investigate if the use of continuous positive air pressure for a short period (7 days), would improve sleep quality, daytime sleepiness, and the disposition for physical activity. Eighty obstructive sleep apnea syndrome patients were randomly assigned as follows: group I - continuous positive air pressure with a steady pressure of 4 cm H2O; group II - ideal therapeutic pressure. After filling out the questionnaires related to the studied variables (International physical activity questionnaire long-form, Epworth sleepiness scale, Pittsburgh sleep quality index), patients underwent a baseline pulmonary function test and continuous positive air pressure titration. After continuous positive air pressure therapy for 4≥ hours a night for 7 consecutive days, patients returned and filled out new (International physical activity questionnaire long-form, Epworth sleepiness scale, Pittsburgh sleep quality index) forms. New spirometry was carried out. 39 patients completed the study. The mean age was 52 ± 11 years old and 28 patients (71.79%) were obese. Both groups were similar for all variables studied at baseline. After Continuous positive air pressure use, patients of group II presented more significant improvements (p < 0.05) for sleep quality and diurnal sleepiness. Time spent with physical activities did not change. Spirometric data were at normal range at baseline. Solely the variable FEF 25%-75% was significantly enhanced (p < 0.05) in group II. Continuous positive air pressure therapy for 1 week, with ideal pressure, improves daytime sleepiness and sleep quality, enhances pulmonary function, but does not change the mean time spent with physical activities.

12 October 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
DSDouglas Inomata Cardoso da Silva
Douglas Inomata Cardoso da Silva
CCCamila de Castro Corrêa
Camila de Castro Corrêa
JBJefferson Luis de Barros
Jefferson Luis de Barros
AMAntonio Carlos Marão
Antonio Carlos Marão
SWSilke Anna Theresa Weber
Silke Anna Theresa Weber
To measure the average time for the diagnosis and for the therapeutic prescription of Continuous Positive Airway Pressure (CPAP) at a hospital in Botucatu Medical School - State University São Paulo, UNESP. A retrospective observational study was carried out by collecting data from the electronic medical records of patients over 18-years of age, who had a diagnostic polysomnography testing scheduled between January and December 2017. Of the 347 patients eligible for the study, 94 (27.1%) missed follow-up and 103 (29.7%) had a referral for CPAP use. Until February 2021, only 37 (35.9%) of these patients had already acquired and were using the device, the remaining 66 (64.1%) were waiting or gave up the therapy. The mean value of the waiting time interval between the referral of the diagnostic test and its performance was equivalent to 197 days (6.5 months). The mean time between diagnostic polysomnography and CPAP prescription was 440-days (14.5-months), with a total mean time of 624 days (21-months). As in other services, the diagnostic-therapeutic flow proved to be highly inefficient, with a long waiting period, difficult access to treatment and a high dropout rate. These findings highlight the need to establish new patient-centered strategies with measures that speed up the flow and facilitate access to CPAP, in order to reduce the morbidity and mortality associated with this condition. Level 3 - Non-randomized controlled cohort/follow-up study Recommendation B.

1 November 2022 in Brazilian Journal of Otorhinolaryngology (Versão em Português)
Verified
Journal Article
Closed access
JPJefferson Luis de Barros Phys
Jefferson Luis de Barros Phys
WRWillian Caetano Rodrigues
Willian Caetano Rodrigues
AMAntônio Carlos Marão
Antônio Carlos Marão
LALetícia Cláudia de Oliveira Antunes
Letícia Cláudia de Oliveira Antunes
STSérgio Henrique Kiemle Trindade
Sérgio Henrique Kiemle Trindade
SWSilke Anna Theresa Weber
Silke Anna Theresa Weber